Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 14. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_758AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI90% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_759AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI60% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_760AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay80 MOI49% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_761AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay120 MOI36% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_762AdenovirusSG611DNAAdenoviridaeNoneYesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay160 MOI30% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_788AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI90% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_789AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI45% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_790AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay80 MOI34% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_791AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay120 MOI11% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_792AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1YesNoNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay160 MOI8% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_817AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 120 ng/mlNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI80% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_818AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 240 ng/mlNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay10 MOI76% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_825AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 120 ng/mlNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI40% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927
OV_826AdenovirusSG611-VSTM1DNAAdenoviridaeA VSTM1 gene expression cassette containing VSTM1 cDNA, cytomegalovirus promoter and SV40 polyA was inserted into the genome of SG611 to generate SG611-VSTM1NoViral strain in combination with DNR 240 ng/mlNoGibco, Thermo Fisher Scientific, Waltham, MA, USAHuman megakaryoblastic leukemic cell lineMEG-011.0E+4 cells per wellSlight toxicity to L-02 and BJ cell lineCell counting kit-8 (CCK-8) assay40 MOI39% cancer cell viability at 72 hoursNoNoNA No responseNAEnhanced apoptosis activation is observedNANA27472927